Variability in Gene Expression Patterns of Ewing Tumor Cell Lines Differing in EWS-FLI1 Fusion Type

Autor: Aryee, Dave N T, Sommergruber, Wolfgang, Muehlbacher, Karin, Dockhorn-Dworniczak, Barbara, Zoubek, Andreas, Kovar, Heinrich

Publikováno v: In Laboratory Investigation 1 December 2000 80(12):1833-1844

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Identifying the druggable interactome of EWS-FLI1 reveals MCL-1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers.

Autor: Tsafou K; Disease Systems Biology, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Current address: Broad Institute of MIT and Harvard, Cambridge, MA, USA., Katschnig AM; Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria., Radic-Sarikas B; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria., Mutz CN; Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria., Iljin K; Medical Biotechnology, VTT Technical Research Centre of Finland, Espoo, Finland., Schwentner R; Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria., Kauer MO; Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria., Mühlbacher K; Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria., Aryee DNT; Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria.; Department of Pediatrics, Medical University of Vienna, Vienna, Austria., Westergaard D; Disease Systems Biology, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Haapa-Paananen S; Medical Biotechnology, VTT Technical Research Centre of Finland, Espoo, Finland., Fey V; Medical Biotechnology, VTT Technical Research Centre of Finland, Espoo, Finland., Superti-Furga G; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Toretsky J; Department of Oncology, Georgetown University, Medical Center, Washington, DC, USA., Brunak S; Disease Systems Biology, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Kovar H; Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria.; Department of Pediatrics, Medical University of Vienna, Vienna, Austria.

Publikováno v: Oncotarget [Oncotarget] 2018 Jul 24; Vol. 9 (57), pp. 31018-31031. Date of Electronic Publication: 2018 Jul 24 (Print Publication: 2018).